Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
5 Worldwide Road Food varieties You Should Attempt- Watch India launch advanced military satellite on rocket's 1st flight since May 2025 failure
- Former biotech CEO sued over COVID vaccine alleged insider trading
- Famous SUVs With Low Energy Utilization In 2024
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- German politician urges more face-to-face interaction in digital age
- Scientists discover black hole flare with the light of 10 trillion suns
- Top Music and Dance Celebration: Which One Gets You Going?
- Find the Historical backdrop of Common liberties: Advancing Equity and Equity Around the world
